Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
Giant cell arteritis (GCA) and polymyalgia rheumatica (RPM) are immune-mediated rheumatic disease (IMRDs), which typically develop in people over 50 years of age. Currently, GCA and PMR are considered within a single complex autoimmune-autoinflammatory pathology, defined as “GCA-PMR spectrum disease...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Sprog: | russisk |
| Udgivet: |
IMA PRESS LLC
2024-09-01
|
| Serier: | Научно-практическая ревматология |
| Fag: | |
| Online adgang: | https://rsp.mediar-press.net/rsp/article/view/3600 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|